These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36265715)

  • 1. Conformity assessment of medicines containing antibiotics - A multivariate assessment.
    Lombardo M; da Silva CM; Lourenço FR
    Regul Toxicol Pharmacol; 2022 Dec; 136():105279. PubMed ID: 36265715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequentist approach for estimation of false decision risks in conformity assessment based on measurement uncertainty of liquid chromatography analytical procedures.
    Separovic L; Rebello Lourenço F
    J Pharm Biomed Anal; 2020 May; 184():113203. PubMed ID: 32114160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of multivariate acceptance limits (guard-bands) applied to pharmaceutical equivalence assessment.
    da Silva CM; Lourenço FR
    J Pharm Biomed Anal; 2023 Jan; 222():115080. PubMed ID: 36191444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of false pharmaceutical equivalence (non-equivalence) decisions due to measurement uncertainty.
    de Godoy Bertanha ML; Lourenço FR
    J Pharm Biomed Anal; 2021 Sep; 204():114269. PubMed ID: 34303215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement uncertainty and risk of false conformity decision in the performance evaluation of liquid chromatography analytical procedures.
    Separovic L; Lourenço FR
    J Pharm Biomed Anal; 2019 Jul; 171():73-80. PubMed ID: 30974411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement uncertainty evaluation and risk of false conformity assessment for microbial enumeration tests.
    Dias FRS; Lourenço FR
    J Microbiol Methods; 2021 Oct; 189():106312. PubMed ID: 34428497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Measurement Uncertainty on Conformity Assessment in Pharmaceutical Drug Products.
    Simabukuro R; Jeong NA; Lourenço FR
    J AOAC Int; 2021 Jun; 104(3):585-591. PubMed ID: 33156342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformity assessment of multicomponent materials or objects: Risk of false decisions due to measurement uncertainty - A case study of denatured alcohols.
    Kuselman I; Pennecchi F; da Silva RJNB; Brynn Hibbert D
    Talanta; 2017 Mar; 164():189-195. PubMed ID: 28107916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of false conformity decisions of multicomponent items controlled by correlated measurement results due to the sharing of analytical steps.
    Lourenço FR; Bettencourt da Silva RJN
    Talanta; 2019 May; 196():174-181. PubMed ID: 30683347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of false conformity assessment applied to automotive fuel analysis: A multiparameter approach.
    de Oliveira EC; Lourenço FR
    Chemosphere; 2021 Jan; 263():128265. PubMed ID: 33297209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement uncertainty for the potency estimation by rapid microbiological methods (RMMs) with correlated data.
    Saviano AM; Bettencourt da Silva RJN; Lourenço FR
    Regul Toxicol Pharmacol; 2019 Mar; 102():117-124. PubMed ID: 30653990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of a false decision on conformity of an environmental compartment due to measurement uncertainty of concentrations of two or more pollutants.
    Pennecchi FR; Kuselman I; da Silva RJNB; Hibbert DB
    Chemosphere; 2018 Jul; 202():165-176. PubMed ID: 29567614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total risk of a false decision on conformity of an alloy due to measurement uncertainty and correlation of test results.
    Kuselman I; Pennecchi FR; da Silva RJNB; Hibbert DB; Anchutina E
    Talanta; 2018 Nov; 189():666-674. PubMed ID: 30086976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement Uncertainty and Conformity Assessment Applied to Drug and Medicine Analyses - A Review.
    Separovic L; Simabukuro RS; Couto AR; Bertanha MLG; Dias FRS; Sano AY; Caffaro AM; Lourenço FR
    Crit Rev Anal Chem; 2023; 53(1):123-138. PubMed ID: 34152871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacopeial specifications and analytical data from post-marketing quality sampling and testing programs: A perspective beyond out-of-specification results.
    Neves EO; de Sales PM; Silveira D
    J Pharm Biomed Anal; 2020 Jan; 178():112935. PubMed ID: 31678550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertainty of measurement for 14 immunoassay analytes: application to laboratory result interpretation.
    Çubukçu HC; Yavuz Ö; Devrim E
    Scand J Clin Lab Invest; 2019; 79(1-2):117-122. PubMed ID: 30626224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical Target Profile: establishment of precision requirements for assay.
    Ermer J
    J Pharm Biomed Anal; 2018 Oct; 160():73-79. PubMed ID: 30071392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring Uncertainty Using Different Approaches: A Case Study for Acetaminophen Quantification.
    J AOAC Int; 2016 Apr; ():. PubMed ID: 27074808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement uncertainty evaluation from correlated validation data: Determination of elemental impurities in pharmaceutical products by ICP-MS.
    Milde D; Pluháček T; Kuba M; Součková J; Bettencourt da Silva RJN
    Talanta; 2020 Dec; 220():121386. PubMed ID: 32928409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of false decision on conformity of a multicomponent material when test results of the components' content are correlated.
    Kuselman I; Pennecchi FR; da Silva RJNB; Hibbert DB
    Talanta; 2017 Nov; 174():789-796. PubMed ID: 28738655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.